A bioimplant is a surgically implanted biomaterial used to replace damaged tissue in the human body for cardiac, orthopedic, and reconstructive purposes. A neurostimulator is an implant that helps reduce the experience of pain by replacing it with a ....see more
The ENT Devices Market is expected to grow from USD 16.2 billion in 2021 to USD 22.3 billion by 2026, at a CAGR of 6.6% during the forecast period. The major players in the ENT Devices market are Karl Storz Gmbh & co. KG (Germany), Medtronic plc (Ireland), Stryker Corporation (US), Olympus Corporation (Japan), Cochlear Limited (Australia), Sonova Holding AG (Switzerland), William Demant holding a/s (Denmark), etc.
Bio-implants can be defined as prostheses used to regularize physiological functions. They are made up of biosynthetic materials like collagen, and tissue-engineered products like artificial skin or tissues. Most bioengineered products like cardiac pacemakers and orthopedic artificial implants are also covered under bio-implants, since they are implanted entirely in the patientís body.
This report provides an in-depth review of the numerous significant developments in neurostimulation technology, and the markets for this technology. It also provides in detail the competitive landscape, profiles of key players and over 100 market related tables on the neurostimulation sector.